Parham َAcademy: the Cheminformatic Central
Drug Discovery Research Groups
We are supervising courses, workshops, and research projects in
cancer pharmacology, molecular modelling, & bioinformatics
Attendance in Symposium & conferences, 2016



My presentations accepted for the "Symposium on Molecular Targets and Cancer Therapeutics", Munich, Germany; jointly organized by AACR and ECCO, Cancer associations of USA and Europe.

So I would be in Germany in 29th of November, 2016, and hope to see you there.



PhD Thesis


Molecular modelling of berberine derivatives as inhibitors of oncogenic signalling pathways on breast cancer cell lines, a novel computational approach


Welcome to Parham Academy


Parham Jabbarzadeh Kaboli (academic name: Parham J. Kaboli) in brief:

- A research leader in cancer drug discovery and cell signalling
- An associate member of the American Association of Cancer Research (AACR)
- A member of the American Society for Pharmacology and Experimental Therapeutics (ASPET)
- A member of the American Association for Advancement of Science (AAAS)

I am strongly seeking a postdoctoral fellowship and highly interested in systems biology, cell signalling, and using algorithms and computational solution to find the best promising anti-cancer drugs to overcome drug resistance and other challenging issues in cancer pharmacology.

I previously worked as university lecturer and laboratory manager for a couple of years, then started my PhD at Univerisiti Putra Malaysia (UPM) in molecular medicine.

As a multidisciplinary scientist, I am involved with

(1) Biological experiments, cellular & molecular approach
(2) Computational biology, molecular modelling, & metaheuristic algorithms
(3) Molecular Pharmacology

all for cancer treatment.

Furthermore,

In addition to my research activities, I am delivering my expertise to the next generation of researchers. Since 2014, therefore, I have established a group of young researchers and teaching them how to perform a modelling and drug discovery project. I am currently analyzing protein/ligand interactions, based on computational and experimental methods.

I am the author of two books and several ISI articles. The list of my publication is available on his official website, and my ResearchGate and Google Scholar profiles.

Contact information:

E-Mail: parham@gromacs.net

Telegram: telegram.me/parhamacademy



This is a bilingual (English/Persian) item.


As we have some colleagues or students who are registering in our courses or services, we officially publish this guideline written by Dr Ramin Sadeghi, associate professor of Mashhad University of Medical Sciences. We strictly follow this guideline in our current or future collaborations.

با توجه به اینکه دوستانی چه از میان اعضای هیات علمی و چه از میان دانشجویان، در پروژه ها، کارگاه ها و خدمات آموزشی ما در حوزه طراحی دارو ثبت نام می کنند ، دستورالعمل درج نام نویسنده که توسط آقای دکتر رامین صادقی، دانشیار دانشگاه علوم پزشکی مشهد، تدوین شده است، بطور رسمی به عنوان دستورالعمل برای تمام پروژه ها و همکاری های آینده قرار می گیرد. لطفا دوستانی که تمایل به تعامل فی ما بین دارند، قبلا این اصول را مطالعه بفرمایند.

ما برای در نظر گرفتن همکاران مان بر روی مقالات مشترک بطور سختگیرانه ای از این اصول تبعیت می کنیم.


چه کسی نویسنده یک مقاله علمی تلقی میشود؟ ملاکهای گنجاندن یک نفر به عنوان نویسنده یک مقاله علمی چیست؟


In the current post, we have explained in detail the criteria of authorship, order of authors, and responsibility of authors according to the accepted international guidelines.


در این پست، ما به تفصیل در مورد ملاکهای نویسندگی، ترتیب نویسندگان، و مسوولیت هر یک از نویسندگان بر اساس گایدلانهای معتبر جهانی بحث خواهیم کرد.


Why authorship is important?

In the scholarly world, authorship is the basis of rewards and career advancement. Grant allocation is usually based on the previous authorship records. Career advancement (for example promotion to associate professor or full professor) is highly dependent on number and quality of the authored material. This is the reason that, authorship is very important in the scholarly arena and there are many legal disputes in this regard.


در دنیای علم، نویسنده بودن مبنای پیشرقت در حرفه دانشگاهی به حساب میرود. اختصاص بودجه و جذب منابع و نیز ارتقا در سمت دانشگاهی بسیار وابسته به تعداد و کیفیت مطالب چاپ شده توسط افراد است. به همین علت، مساله معیارهای نویسندگی در جهان علم بسیار مهم بوده و منشا بسیاری از اختلافات حقوقی می باشد.

Author watson Home 13:06:25 | Comments:0 | | printer friendly | | create pdf of this news item



Cell & Molecular Biology | Drugs and Pharmacology | Bioinformatics

Systems Biology

Animal Sciences | Plant Sciences | Foreign  Language

Books Collection | Articles Collection

Library management software

IELTS

Author watson Home 13:34:45 | Comments:0 | | printer friendly | | create pdf of this news item



Each weekend, you are linked to the best article that , during each week, I have read and found it great in the field of Cancer and Pharmacology. I try to encourage the fellow researchers and post-graduate students to read so much as they can about new therapeutics.
-------------------------------------------

Weekend Recipe for February 2016 - the fourth week

The birth of modern chemotherapy

This paper published in the Pharmacologist is very interesting showing you how chemotherapy has been evolved as a tool to treat cancer.


Download this recipe

To download other weekend recipes click here.
Author watson Home 15:56:31 | Comments:0 | | printer friendly | | create pdf of this news item



Each weekend, you are linked to the best article that , during each week, I have read and found it great in the field of Cancer and Pharmacology. I try to encourage the fellow researchers and post-graduate students to read so much as they can about new therapeutics.
-------------------------------------------

Weekend Recipe for February 2016 - the second week

The impact of molecular dynamics on drug design: applications for the characterization of ligand– macromolecule complexes

This week I would like to suggest this paper. This paper is very great review paper which is useful for those are interested in drug discovery and are got a little bit confused.

Abstract——Among all tools available to design new drugs, molecular dynamics (MD) simulations have become an essential technique. Initially developed to investigate molecular models with a limited number of atoms, computers now enable investigations of large macromolecular systems with a simulation time reaching the microsecond range.

The reviewed articles cover four years of research to give an overview on the actual impact of MD on the current medicinal chemistry landscape with a particular emphasis on studies of ligand–protein interactions. With a special focus on studies combining computational approaches with data gained from other techniques, this review shows how deeply embedded MD simulations are in drug design strategies and articulates what the future of this technique could be.


Download this recipe

If interested in the field of drug discovery I would also like to suggest these articles. These are well-written too.

To download other weekend recipes click here.

Author watson Home 07:53:45 | Comments:0 | | printer friendly | | create pdf of this news item


Go to page  1 2 3
Archives

The fifth Recipe - February 2016 - the first week watson @ (21:38:55) (Weekend Recipe: For further reading)
Published Articles watson @ (11:59:34) (Curriculum Vitae)
The seventh Recipe - February 2016: the third week watson @ (06:44:52) (Weekend Recipe: For further reading)
The fourth Recipe - January 2016 - the fourth week watson @ (14:57:18) (Weekend Recipe: For further reading)


Headlines


»Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications
Publication date: November 2016 Source:Cancer Treatment Reviews, Volume 50 Author(s ...
»Extreme hypofractionation for early prostate cancer: Biology meets technology
Publication date: November 2016 Source:Cancer Treatment Reviews, Volume 50 Author(s ...
»Role and therapeutic potential of CDK12 in human cancers
Publication date: November 2016 Source:Cancer Treatment Reviews, Volume 50 Author(s ...
»Improving outcomes for older women with gynaecological malignancies
Publication date: November 2016 Source:Cancer Treatment Reviews, Volume 50 Author(s ...
»Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
Publication date: November 2016 Source:Cancer Treatment Reviews, Volume 50 Author(s ...


Date published: not known
Details

»Editorial Advisory Board
Publication date: 1 October 2016 Source:Biochemical Pharmacology, Volume 117
»Soluble Immune Response Suppressor (SIRS): Reassessing the immunosuppressant potential of an elusive peptide
Publication date: 1 October 2016 Source:Biochemical Pharmacology, Volume 117 Author ...
»Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy
Publication date: 1 October 2016 Source:Biochemical Pharmacology, Volume 117 Author ...
»Dehydroepiandrosterone-induced changes in mitochondrial proteins contribute to phenotypic alterations in hepatoma cells
Publication date: 1 October 2016 Source:Biochemical Pharmacology, Volume 117 Author ...
»Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1
Publication date: 1 October 2016 Source:Biochemical Pharmacology, Volume 117 Author ...


Date published: not known
Details

»Modeling the Effects of Morphine on Simian Immunodeficiency Virus Dynamics
»Template-Based Modeling of Protein-RNA Interactions
»Cytofkit: A Bioconductor Package for an Integrated Mass Cytometry Data Analysis Pipeline
»Immersed Boundary Models for Quantifying Flow-Induced Mechanical Stimuli on Stem Cells Seeded on 3D Scaffolds in Perfusion Bioreactors
»Forecasting Human African Trypanosomiasis Prevalences from Population Screening Data Using Continuous Time Models
»In Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic Model
»Separating Timing, Movement Conditions and Individual Differences in the Analysis of Human Movement
»Error Correction and the Structure of Inter-Trial Fluctuations in a Redundant Movement Task
»M-Track: A New Software for Automated Detection of Grooming Trajectories in Mice
»Gamma Synchronization Influences Map Formation Time in a Topological Model of Spatial Learning
»How to Distinguish Conformational Selection and Induced Fit Based on Chemical Relaxation Rates
»Estimating Copy Number and Allelic Variation at the Immunoglobulin Heavy Chain Locus Using Short Reads


Date published: not known
Details


PARHAM'S CURRENT POSITION

Parham Jabbarzadeh Kaboli

Lecturer and Researcher
in Molecular Pharmacology

Expert in:

Cell and molecular Biology
Modelling and drug discovery
Cancer signaling pathways

H-index= 3 (Google Scholar)
i10-index= 3
Overall impact factor= 7.55
Overall citation= 70 (Google Scholar)

Memberships:

The American Society for Pharmacology and Experimental Therapeutics (ASPET)

American Association of Cancer Research (AACR)

American Association for Advancement of Science (AAAS)

CONTACT INFORMATION


Affiliation:
Department of Biomedical Science,
Faculty of Medicine and Health Sciences,
Universiti Putra Malaysia,
UPM Serdang 43400,
Selangor, Malaysia

E-Mail: parham@gromacs.net
Telegram: telegram.me/parhamacademy
Featured Publication





View the full list.
Personally Subscribed Journals




Welcome

Username:

Password:



[ ]
Archives








This site is powered by Parham Academy.
This site is powered by Parham Academy.
Render time: 0.2923 sec, 0.1282 of that for queries.